Home » Topics » Regulatory » Patents

Patents
RSS

Chinese researchers report CDK/cyclin inhibitors for cancer

Nov. 11, 2016

Jiangsu Hansoh Pharmaceutical patents FXR agonists

Nov. 11, 2016

Lead Discovery Center and Qurient present TAM receptor kinases and/or MET inhibitors

Nov. 10, 2016

Kainos Medicine develops Brd inhibitors

Nov. 10, 2016

Takeda Pharmaceutical describes orexin receptor antagonists

Nov. 10, 2016

ViiV Healthcare UK discloses antiviral agents

Nov. 10, 2016

Sumitomo Dainippon Pharma patents dopamine D4 receptor agonists

Nov. 10, 2016

Shionogi presents P2X7 antagonists

Nov. 9, 2016

Takeda Pharmaceutical develops SPT inhibitors

Nov. 9, 2016

Araxes Pharma describes mutant K-RAS, H-RAS or N-RAS inhibitors

Nov. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...